J. Glaholm

发表

Twelve cases of glottic carcinoma in situ treated by radiotheraphy: an observation on clinical course versus response

D. W. Morgan, J. Brooks, J. Glaholm, 1993, The Journal of Laryngology & Otology.

Hodgkin's Disease of the Epididymis and Testis

A. Horwich, M. Brada, J. Glaholm, 1989, Journal of the Royal Society of Medicine.

Multicentre prospective audit of surgical outcomes and acute complications following short course pre‐operative radiotherapy for resectable rectal cancer

C. McConkey, A. Hartley, F. Adab, 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).

M. Parmar, M. Sydes, D. Dearnaley, 2007, Journal of the National Cancer Institute.

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer

N. James, D. Stocken, D. Peake, 2004, British Journal of Cancer.

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma

J. Ansari, S. Hussain, J. Glaholm, 2013, Biologics : targets & therapy.

Pulmonary Toxicity with Oxaliplatin and Capecitabine/5-Fluorouracil Chemotherapy: A Case Report and Review of the Literature

J. Glaholm, B. A. Choo, A. Chan, 2011, Oncology Research and Treatment.

Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study

A. Darzi, R. Peto, P. Ziprin, 2020, The lancet. Gastroenterology & hepatology.

Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemoradiation schedules in head and neck cancer

P. Sanghera, A. Hartley, J. Glaholm, 2014, Tumor Biology.

Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?

A. Hartley, P. Sanghera, A. Hartley, 2013, The British journal of radiology.

External beam radiotherapy in the management of differentiated thyroid cancer.

C. McConkey, J. Watkinson, A. Hartley, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Four Week Hypofractionated Accelerated Intensity Modulated Radiotherapy and Synchronous Carboplatin or Cetuximab in Biologically Staged Oropharyngeal Carcinoma

A. Hartley, H. Mehanna, J. Hodson, 2014 .

The use of MuGard™, Caphosol ® and Episil ® in patients undergoing chemoradiotherapy for squamous cell carcinoma of the head and neck

A. Hartley, P. Sanghera, J. Glaholm, 2014 .

A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

N. James, D. Peake, D. Wallace, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

An assessment of the sensitivity of in vivo 31P nuclear magnetic resonance spectroscopy as a means of detecting pH heterogeneity in tumours: a simulation study.

M. Leach, J. Glaholm, A. Madden, 1990, The British journal of radiology.

Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.

J. Fowler, C. McConkey, A. Hartley, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

A. Hackshaw, I. Hutchison, J. Tobias, 2009, The Lancet. Oncology.

Elective Management of the Neck in Parotid Tumours.

B. Ng-Cheng-Hin, D. Gujral, J. Glaholm, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review

S. Rizwan, J. Ansari, Pawan Kumar, 2021, Gynecologic Oncology Reports.

The psychosocial impact of head and neck cancer.

J. Watkinson, P. Pracy, J. Glaholm, 2001, Clinical otolaryngology and allied sciences.

Carboplatin and hypofractionated accelerated radiotherapy: a dose escalation study of an outpatient chemoradiation schedule for squamous cell carcinoma of the head and neck.

J. Watkinson, A. Hartley, J. Glaholm, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel

J. Werner, A. Dietz, G. Dyckhoff, 2002, British Journal of Cancer.

Comparison of 5-fluorouracil pharmacokinetics following intraperitoneal and intravenous administration using in vivo 19F magnetic resonance spectroscopy.

V. R. McCready, D. Collins, M. Leach, 1990, The British journal of radiology.

Clinical 19F Nuclear Magnetic Resonance Spectroscopy in Colorectal Cancer: Monitoring Low-Level 5-Fluorouracil Infusion Therapy and the Metabolic Effects of Additive α-Interferon

V. R. McCready, D. Collins, M. Leach, 1992 .

Chemoradiation in head and neck cancer

J. Glaholm, N. Walji, 2012 .

The use of bisphosphonates in prostatic cancer.

D. Dearnaley, M. Mason, J. Glaholm, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Carboplatin (JM8), etoposide (VP16) and thoracic irradiation for small cell lung cancer (S.C.L.C.): an evaluation of lung toxicity.

J. Yarnold, I. Smith, G. Cherryman, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience.

A. Zarkar, J. Ansari, S. Hussain, 2008, Oncology reports.

Vomiting associated with whole body irradiation.

A. Barrett, C. Westbrook, J. Glaholm, 1987, Clinical radiology.

Conservation surgery in the management of T1 and T2 oropharyngeal squamous cell carcinoma: the Birmingham UK experience.

J. Watkinson, J. Glaholm, A. D. Das Gupta, 2002, Clinical otolaryngology and allied sciences.

Prostate cancer--what should be studied?

J. Glaholm, N. James, 1995, European journal of cancer.

A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.

A. Graeff, M. Leach, I. Smith, 1991, British Journal of Cancer.

Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.

C. McConkey, A. Hartley, H. Mehanna, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Head and Neck HYPOFRACTIONATED ACCELERATED RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

C. McConkey, P. Sanghera, J. Glaholm, 2007 .

Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.

J. Fowler, C. McConkey, G. Fountzilas, 2013, International journal of radiation oncology, biology, physics.

Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck.

J. Fowler, C. McConkey, A. Hartley, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham experience.

A. Marshall, A. Hartley, J. Glaholm, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Developments in radiotherapy and adjuvant chemotherapy for head and neck cancer.

J. Watkinson, J. Glaholm, 2003, Clinical otolaryngology and allied sciences.

The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study.

V. R. McCready, D. Collins, M. Leach, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

A comparison ofinvivo andinvitro 31P NMR spectra fromhumanbreast tumours: Variations inphospholipid metabolism

V. R. McCready, D. Collins, M. Leach, 1991 .

The effect of intra‐tumour heterogeneity on the distribution of phosphorus‐containing metabolites within human breast tumours: An In Vitro study using 31P NMR spectroscopy

V. R. McCready, M. Leach, T. A. Smith, 1991, NMR in biomedicine.

The effect of head and neck irradiation on taste dysfunction: a prospective study.

L. Billingham, J. Henk, I. Fernando, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Cartilage: the 'F'-factor fallacy.

J. Glaholm, J. Townley, P. Atherton, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

Abstracts from meeting 23 October 1992

M. Brada, D. Uttley, J. Glaholm, 1993, The Journal of Laryngology & Otology.

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

R. A. Jones, M. F. Smith, R. Peto, 1997, British journal of urology.

Concurrent use of nivolumab and radiotherapy for patients with metastatic non-small cell lung cancer and renal cell carcinoma with oligometastatic disease progression on nivolumab

J. Ansari, A. Farrag, J. Glaholm, 2021, Molecular and clinical oncology.

Radiotherapy and chemotherapy

J. Glaholm, 2002 .

Rare Case of Intracardiac Renal Cell Carcinoma Metastasis with Response to Nivolumab: Case Report and Literature Review

J. Ansari, A. Farrag, J. Glaholm, 2018, Case Reports in Oncology.

Variation in volume definition between UK head and neck oncologists treating oropharyngeal carcinoma.

A. Hartley, H. Mehanna, P. Sanghera, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment

T. Powles, D. Collins, M. Leach, 1998, NMR in biomedicine.

The sequential use of abiraterone and enzalutamide (MDV3100) in castrate resistant prostate cancer patients: Experience from Birmingham, United Kingdom.

N. James, E. Porfiri, A. Zarkar, 2013 .

The Role of Radiotherapy in the Management of Intracranial Meningiomas

H. Bloom, M. Khouchani, J. Glaholm, 2017 .

A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.

V. R. McCready, D. J. Collins, D. Collins, 1991, British Journal of Cancer.

Anaplastic Thyroid Cancer

J. Glaholm, C. Connolly, 2014 .

A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.

I. Ellis, E. Jones, J. Child, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck—A Low α/β?

H. Mehanna, A. Hartley, J. Glaholm, 2018, Medicines.

Can synchronous chemotherapy be added to accelerated hypofractionated radiotherapy in patients with base of tongue cancer?

N. Slevin, A. Hartley, R. Swindell, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision

A. Darzi, R. Peto, P. Ziprin, 2022, The Lancet. Healthy longevity.

Panoramic Radiobiological Modelling of the Contribution of Concomitant Chemotherapy to Biological Effective Dose in Squamous Cell Carcinoma

A. Hartley, P. Sanghera, J. Glaholm, 2014 .

The sequential use of abiraterone and enzalutamide in metastatic castrate resistant prostate cancer patients: Experience from seven U.K. centers.

N. James, E. Porfiri, A. Zarkar, 2014 .

Concurrent nivolumab and radiotherapy to improve outcomes for patients with metastatic lung and renal cancers.

S. Hussain, J. Ansari, F. Bashir, 2018 .

Conservation surgery in head and neck cancer.

J. Watkinson, J. Glaholm, I. Sheppard, 1998, Clinical otolaryngology and allied sciences.

Developments in radiotherapy for head and neck cancer

J. Glaholm, 2008 .

Docetaxel re-treatment for metastatic hormone refractory prostate cancer

A. Zarkar, J. Ansari, S. Hussain, 2008 .

De novo laryngeal carcinoma in childhood.

K. Pearman, J. Glaholm, M. Macnamara, 2000, The Journal of laryngology and otology.

Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.

C. McConkey, P. Sanghera, A. Hartley, 2007, International journal of radiation oncology, biology, physics.

The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-α using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: A pilot study

V. R. McCready, D. Collins, M. Leach, 1993 .

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

A. Hackshaw, I. Hutchison, J. Tobias, 2009, The Lancet. Oncology.

Does chemotherapy have a role in the management of patients with advanced head and neck cancer? Early results from the UK Head and Neck (UKHAN) Trial

J. Peto, J. Tobias, K. Monson, 2001 .

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

A. Hackshaw, I. Hutchison, J. Tobias, 2010 .

The management of squamous cell carcinoma of the neck. The Birmingham UK experience.

J. Watkinson, J. Glaholm, N. Mastronikolis, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

IN-VIVO 31P MAGNETIC RESONANCE SPECTROSCOPY FOR MONITORING TREATMENT RESPONSE IN BREAST CANCER

D. Collins, M. Leach, J. Mansi, 1989, The Lancet.

R. A. Jones, R. Peto, S. Parish, 1997, British Journal of Urology.

Post-operative accelerated hypofractionated radiotherapy for adenoid cystic carcinoma

C. McConkey, J. Sherriff, P. Sanghera, 2010, Journal of Radiotherapy in Practice.

University of Birmingham Post-operative accelerated hypofractionated radiotherapy for adenoid cystic carcinoma

P. Sanghera, J. Glaholm, U. Barthakur, 2011 .

The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients.

H. Bloom, J. Glaholm, J. Crow, 1990, International journal of radiation oncology, biology, physics.

Pulmonary Toxicity with Oxaliplatin and Capecitabine/5-Fluorouracil Chemotherapy: A Case Report and Review of the Literature

J. Glaholm, B. A. Choo, A. Chan, 2011, Oncology Research and Treatment.

Role of second-line systemic treatment post-docetaxel in metastatic castrate resistant prostate cancer- current strategies and future directions.

J. Ansari, S. Hussain, A. Alhasso, 2011, Anti-cancer agents in medicinal chemistry.

Soft-tissue sarcoma: neutrons versus photons for post-operative irradiation.

J. Glaholm, C. Harmer, 1988, The British journal of radiology.